Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Streptomyces sp. MUM256: A Source for Apoptosis Inducing and Cell Cycle-Arresting Bioactive Compounds against Colon Cancer Cells. | Cancers (Basel) | 2019 | 31698795 | PubTator, text mining | PubMed |
| Nanomedicine Against Aβ Aggregation by β-Sheet Breaker Peptide Delivery: In Vitro Evidence. | Pharmaceutics | 2019 | 31683907 | PubTator, text mining | PubMed |
| Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer. | Mol Ther Methods Clin Dev | 2019 | 31660419 | PubTator, text mining | PubMed |
| Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis via synergistic upregulation of ALAS1 expression. | Acta Pharm Sin B | 2019 | 31649844 | PubTator, text mining | PubMed |
| In vitro differentiation of cGMP-grade retinal pigmented epithelium from human embryonic stem cells. | Int J Retina Vitreous | 2019 | 31646003 | PubTator, text mining | PubMed |
| Validation of Reference Genes for Normalization of Relative qRT-PCR Studies in Papillary Thyroid Carcinoma. | Sci Rep | 2019 | 31645594 | PubTator, text mining | PubMed |
| NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA. | Int J Oncol | 2019 | 31638184 | PubTator, text mining | PubMed |
| Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma. | EBioMedicine | 2019 | 31628025 | PubTator, text mining | PubMed |
| Growth and neurite stimulating effects of the neonicotinoid pesticide clothianidin on human neuroblastoma SH-SY5Y cells. | Toxicol Appl Pharmacol | 2019 | 31626844 | PubTator, text mining | PubMed |
| Sylvatic cycles of arboviruses in non-human primates. | Parasit Vectors | 2019 | 31578140 | PubTator, text mining | PubMed |
| Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review. | Cancer Manag Res | 2019 | 31576171 | PubTator, text mining | PubMed |
| Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases. | Front Pharmacol | 2019 | 31572192 | PubTator, text mining | PubMed |
| Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria. | Front Pharmacol | 2019 | 31572191 | PubTator, text mining | PubMed |
| Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men. | J Cachexia Sarcopenia Muscle | 2019 | 31568675 | PubTator, text mining | PubMed |
| An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress? | Chin J Cancer Res | 2019 | 31564802 | PubTator, text mining | PubMed |
| Axonal Polyneuropathy in a Man Treated for Pulmonary Cocci: A Case of Acute Intermittent Porphyria. | Am J Case Rep | 2019 | 31530795 | PubTator, text mining | PubMed |
| MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro: Clinical Implications. | OMICS | 2019 | 31526233 | PubTator, text mining | PubMed |
| Cell cycle regulators control mesoderm specification in human pluripotent stem cells. | J Biol Chem | 2019 | 31515269 | PubTator, text mining | PubMed |
| Selection of an inadequate housekeeping gene leads to misinterpretation of target gene expression in zinc deficiency and zinc supplementation models. | J Trace Elem Med Biol | 2019 | 31513994 | PubTator, text mining | PubMed |
| Proteolytic Control of Lipid Metabolism. | ACS Chem Biol | 2019 | 31503446 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=55